$3,059.48 travel Payment -- Sanofi to Dr. Rebecca Adams

Sanofi covers travel costs for Endocrinology specialist Rebecca Adams related to Tecfidera.

This page provides a detailed analysis of a $3,059.48 travel payment from Sanofi to Dr. Rebecca Adams. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$3,059.48
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanySanofi
PhysicianDr. Rebecca Adams
NPI Number1004546060
Physician SpecialtyEndocrinology
LocationSpringfield, MA
Date of Payment2025-08-25
Related Drug/DeviceTecfidera
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Sanofi made a $3.1K travel payment to Rebecca Adams, a Endocrinology specialist in Springfield, MA. The payment was associated with Tecfidera. Sanofi paid $3,059.48 for travel and lodging expenses for Dr. Rebecca Adams. The payment was associated with Tecfidera, an indication of potential influence on prescribing habits. The payment occurred on August 25, 2025, in Springfield, MA.

Patient Guidance: What This Payment Means for You

If your doctor receives travel support from pharmaceutical companies, it's for educational purposes related to new treatments. Always discuss treatment options openly with your doctor. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Travel and lodging payments are common in Endocrinology, often supporting attendance at medical conferences or educational symposia related to treatments like Tecfidera.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging are reportable under the Sunshine Act, requiring disclosure to ensure transparency in physician-pharma relationships.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $3.1K payment for?

This was a travel payment of $3.1K from Sanofi to Rebecca Adams, categorized as "Travel and Lodging". It was associated with Tecfidera. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Rebecca Adams accept pharmaceutical money?

Yes, Rebecca Adams received this $3.1K payment from Sanofi. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Rebecca Adams's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $3.1K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Endocrinology?

To compare this payment against Endocrinology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Endocrinology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Rebecca Adams's relationship with Sanofi?

The payment amount is moderate, suggesting it covers specific travel events rather than extensive trips. This $3.1K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Endocrinology?

The payment type is 'travel', which is common for educational events or consultations.

What should patients do after learning about this payment?

If your doctor receives travel support from pharmaceutical companies, it's for educational purposes related to new treatments. Always discuss treatment options openly with your doctor.

What else should I know about this travel payment?

The drug associated, Tecfidera, is a significant product for Sanofi in the neurology/immunology space.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.